Maternal β‐Nicotinamide Mononucleotide Supplementation Reduces the IUGR Rate by Improving Mitochondrial Function in the Placenta of Sows via AMPK/PGC‐1α Pathway
Molecular Nutrition & Food Research · 2025
DOI: 10.1002/mnfr.70061 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2025. Verfasst von Zhefeng Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Fetal Growth Retardation, Nicotinamide Mononucleotide, Mitochondria, Placenta. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Nature Science Foundation of China, National key R&D program of China, Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project.
Abstract (Originalsprache)
Metabolic disturbances in late gestation contributes to oxidative stress and mitochondrial dysfunction in the placenta, leading to intrauterine growth retardation (IUGR), all of which are associated with reduced nicotinamide adenine dinucleotide (NAD + ) levels. This study aimed to investigate the effects of maternal supplementation of β‐nicotinamide mononucleotide (NMN), a nutraceutical NAD + precursor, on IUGR rate and its underlying mechanisms. A total of 24 sows were randomly divided into either the control or NMN group, with each sow in the NMN group receiving 0.2 g of NMN per day. The results demonstrated that NMN supplementation significantly reduced the IUGR rate and increased NAD + levels in the placenta of sows. Furthermore, NMN supplements upregulated mRNA and protein expressions of key mitochondrial regulators, such as PGC‐1α, declined oxidative stress and apoptosis, and improved lipid metabolism in the placenta. These effects were linked to the upregulation of p‐AMPK and the downregulation expression of p‐mTOR. Taken together, this study indicates that maternal NMN supplementation reduces the IUGR rate by improving mitochondria function, enhancing lipid metabolism, and declining oxidative stress in the placenta.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha, Hunan, China.
- College of Advanced Agricultural Sciences, University of Chinese Academy of Sciences, Beijing, China.
- Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China.
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China.
- Center for Obesity and Metabolic Diseases Research, School of Basic Medicine, Chongqing Medical University, Chongqing, China.
ORCID-Profile: Zhefeng Wang
Förderung
- National Nature Science Foundation of China
- National key R&D program of China
- Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project
- Natural sciences foundation of Chongqing
Zitieren
APA
Wang, Z., Zhou, T., Shao, M., Du, J., Li, Y., Wang, S., & Wu, X. (2025). Maternal β‐Nicotinamide Mononucleotide Supplementation Reduces the IUGR Rate by Improving Mitochondrial Function in the Placenta of Sows via AMPK/PGC‐1α Pathway. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.70061
Vancouver
Wang Z, Zhou T, Shao M, Du J, Li Y, Wang S, et al. Maternal β‐Nicotinamide Mononucleotide Supplementation Reduces the IUGR Rate by Improving Mitochondrial Function in the Placenta of Sows via AMPK/PGC‐1α Pathway. Molecular Nutrition & Food Research. 2025. doi:10.1002/mnfr.70061
BibTeX
@article{Wang2025,
author = {Wang, Zhefeng and Zhou, Tiantian and Shao, Muyang and Du, Jiajun and Li, Yumeng and Wang, Shujin and Wu, Xin},
title = {Maternal β‐Nicotinamide Mononucleotide Supplementation Reduces the IUGR Rate by Improving Mitochondrial Function in the Placenta of Sows via AMPK/PGC‐1α Pathway},
journal = {Molecular Nutrition & Food Research},
year = {2025},
doi = {10.1002/mnfr.70061}
}
EUVIMED